Raunak Parikh

GlaxoSmithKline (Belgium) — Belgium

Medicine · Health Sciences

12h-index510citations25works12.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Herpesvirus Infections and Treatments(17), Acne and Rosacea Treatments and Effects(9), Bartonella species infections research(7), Vaccine Coverage and Hesitancy(5), SARS-CoV-2 and COVID-19 Research(4)

Publications25 total

Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment
Human Vaccines & Immunotherapeutics·2025Open Access
Breaking the cycle: considerations for a life-course vaccination strategy against varicella-zoster virus
Expert Review of Vaccines·2025· 2 citedOpen Access
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment
Human Vaccines & Immunotherapeutics·2025· 1 citedOpen Access
Herpes Zoster Ophthalmicus: Presentation, Complications, Treatment, and Prevention
Infectious Diseases and Therapy·2024· 35 citedOpen Access
A systematic literature review of the epidemiology and burden of herpes zoster in selected locales in Asia Pacific
Human Vaccines & Immunotherapeutics·2024· 14 citedOpen Access
Knowledge, attitude, and practice toward herpes zoster (HZ) and HZ vaccination: Concept elicitation findings from a multi-country study in the Asia Pacific
Human Vaccines & Immunotherapeutics·2024· 12 citedOpen Access
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review
Infectious Diseases and Therapy·2024· 9 citedOpen Access
Herpes Zoster Recurrence: A Narrative Review of the Literature
Dermatology and Therapy·2024· 28 citedOpen Access
Co-administration of the adjuvanted recombinant zoster vaccine with other adult vaccines: An overview
Vaccine·2024· 10 citedOpen Access
Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
Human Vaccines & Immunotherapeutics·2023· 36 citedOpen Access
An update on national recommendations for the use of the adjuvanted recombinant zoster vaccine
European Journal of Public Health·2022· 2 citedOpen Access
The impact of the COVID-19 pandemic on the incidence of herpes zoster
European Journal of Public Health·2022Open Access
Increased Risk of Herpes Zoster in Adults ≥50 Years Old Diagnosed With COVID-19 in the United States
Open Forum Infectious Diseases·2022· 59 citedOpen Access
Herpes zoster in outpatient departments of healthcare centers in India: a review of literature
Human Vaccines & Immunotherapeutics·2021· 19 citedOpen Access
Diphtheria-tetanus-pertussis (DTP) vaccination: understanding the perspectives and expectations of parents and healthcare professionals in France and India
Human Vaccines & Immunotherapeutics·2021Open Access
A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations
Expert Review of Vaccines·2021· 44 citedOpen Access
Correction to: Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
Dermatology and Therapy·2021· 16 citedOpen Access
Can COVID-19 Increase the Risk of Herpes Zoster? A Narrative Review
Dermatology and Therapy·2021· 73 citedOpen Access
Towards adult vaccination in India: a narrative literature review
Human Vaccines & Immunotherapeutics·2019· 59 citedOpen Access
Hexavalent Vaccines in India: Current Status
Indian Pediatrics·2019· 7 cited
page 1 of 2Next →

Frequent Co-authors

Nicolas Lecrenier(5), Shafi Kolhapure(4), Sumitra Shantakumar(4), Amit Bhavsar(3), Robyn Widenmaier(3), Javier Díez‐Domingo(2), Elisa Cisneros(2), Natalia McCormick(2), Gita Nataraj(2), Vijay Khatri(2), Resham Dash(2), Ashish Agrawal(2), Christophe Dessart(2), John Litt(2), Jing Chen(2), Hyung-Woo Kim(2), G. Casabona(2), Liesel D’silva(2), A S Nanivadekar(2), Sadhna Joglekar(2)